Eczema drugs tacrolimus (Protopic) and pimecrolimus (Elidel): cancer concerns
AUTOR(ES)
Wooltorton, Eric
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=557066Documentos Relacionados
- Drugs and surgical concerns
- Tacrolimus 0.1% matches potent steroids in eczema
- Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomised controlled trials
- Do it yourself cancer gene testing raises concerns
- Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study